Biguanides suppress hepatic glucagon signaling by decreasing production of cyclic AMP
Main Authors: | Miller, Russell A., Chu, Qingwei, Xie, Jianxin, Foretz, Marc, Viollet, Benoit, Birnbaum, Morris J. |
---|---|
Format: | Online |
Language: | English |
Published: |
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573218/ |
Similar Items
-
AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B
by: Johanns, M., et al.
Published: (2016) -
AMPK Activation Reduces Hepatic Lipid Content by Increasing Fat Oxidation In Vivo
by: Marc Foretz, et al.
Published: (2018-09-01) -
Effects of biguanides on oxidative phosphorylation
by: Hirst, Judy
Published: (2014) -
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
by: Stephenne, X., et al.
Published: (2011) -
Biguanides and targeted anti-cancer treatments
by: Hanly, Elyse K., et al.
Published: (2015)